Lapatinib Terminated Phase 0 Trials for Epithelial Cancer Treatment
DB01259 (Lapatinib)| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Terminated | Treatment | 0 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT01427322 | Randomized RT +/- Lapatinib for Advanced Solid Tumor Cancer Patients Receiving Radiation Therapy for Metastatic Disease |